May 24, 2019 / 5:07 PM / a month ago

BRIEF-Avexis Says Annualized Cost Of Zolgensma Is USD 425,000 Per Year For 5 Years

May 24 (Reuters) - Novartis AG:

* AVEXIS - ANNUALIZED COST OF ZOLGENSMA IS USD 425,000 PER YEAR FOR 5 YEARS

* AVEXIS - WORKING CLOSELY WITH PAYERS TO CREATE 5-YEAR OUTCOMES-BASED AGREEMENTS AND NOVEL PAY-OVER-TIME OPTIONS

* AVEXIS - AVEXIS HAS PARTNERED WITH ACCREDO® TO OFFER A PAY-OVER-TIME OPTION OF UP TO 5 YEARS TO HELP EASE POSSIBLE SHORT-TERM BUDGET CONSTRAINTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below